Institutional investors purchased a net $2.8 million shares of IMMU during the quarter ended September 2016, and now own 50.71% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VENBIO SELECT ADVISOR LLC Bought 1.9 Million shares of Immunomedics Inc
CANDRIAM BELGIUM SA Bought 75.0 Thousand shares of Immunomedics Inc
CREATIVE PLANNING, INC. Bought 8.4 Thousand shares of Immunomedics Inc